Next report date
Report period
Q1 2024
EPS estimate
−0.04CHF
Revenue estimate
19.58 MCHF
−0.332CHF
−7.11 MCHF
70.40 MCHF
29.04 M
About Rockwell Medical, Inc.
Sector
Industry
CEO
Mark Strobeck
Website
Headquarters
Wixom
Employees (FY)
237
Founded
1996
FIGI
BBG017ZFHKY1
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RWMA is 4.000 CHF — it has increased by 127.40% in the past 24 hours. Watch ROCKWELL MEDICAL I stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ROCKWELL MEDICAL I stocks are traded under the ticker RWMA.
ROCKWELL MEDICAL I is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
RWMA stock is 56.03% volatile and has beta coefficient of 3.08. Track ROCKWELL MEDICAL I stock price on the chart and check out the list of the most volatile stocks — is ROCKWELL MEDICAL I there?
RWMA earnings for the last quarter are −0.06 CHF per share, whereas the estimation was −0.10 CHF resulting in a 33.33% surprise. The estimated earnings for the next quarter are −0.06 CHF per share. See more details about ROCKWELL MEDICAL I earnings.
ROCKWELL MEDICAL I revenue for the last quarter amounts to 21.76 M CHF despite the estimated figure of 20.92 M CHF. In the next quarter revenue is expected to reach 19.06 M CHF.
Yes, you can track ROCKWELL MEDICAL I financials in yearly and quarterly reports right on TradingView.
RWMA stock hasn't changed in a week, the last month showed zero change in price, over the last year ROCKWELL MEDICAL I has showed a 127.40% increase.
RWMA net income for the last quarter is −1.27 M CHF, while the quarter before that showed −1.71 M CHF of net income which accounts for 25.72% change. Track more ROCKWELL MEDICAL I financial stats to get the full picture.
Today ROCKWELL MEDICAL I has the market capitalization of 42.28 M, it has increased by 55.41% over the last week.
No, RWMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RWMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCKWELL MEDICAL I stock right from TradingView charts — choose your broker and connect to your account.
RWMA reached its all-time high on Jun 2, 2023 with the price of 4.000 CHF, and its all-time low was 1.759 CHF and was reached on May 20, 2022. View more price dynamics on RWMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 5, 2024, the company has 237.00 employees. See our rating of the largest employees — is ROCKWELL MEDICAL I on this list?
We've gathered analysts' opinions on ROCKWELL MEDICAL I future price: according to them, RWMA price has a max estimate of 8.08 CHF and a min estimate of 4.49 CHF. Watch RWMA chart and read a more detailed ROCKWELL MEDICAL I stock forecast: see what analysts think of ROCKWELL MEDICAL I and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCKWELL MEDICAL I EBITDA is −3.54 M CHF, and current EBITDA margin is −6.25%. See more stats in ROCKWELL MEDICAL I financial statements.